| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 6e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.24 | 3e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.51 | 0.0009 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |